Detalhe da pesquisa
1.
Indirect treatment comparisons of the gene therapy etranacogene dezaparvovec versus extended half-life factor IX therapies for severe or moderately severe haemophilia B.
Haemophilia
; 30(1): 75-86, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37902714
2.
Assessing prophylactic use and clinical outcomes in hemophilia A patients treated with rVIII-SingleChain and other common rFVIII products in Germany.
Eur J Haematol
; 104(4): 310-317, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31883398
3.
Impact of the change of copay policy in Medicare Part D on zoster vaccine uptake among Medicare beneficiaries in a managed care organization.
BMC Health Serv Res
; 17(1): 503, 2017 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28732518
4.
A budget impact analysis comparing a Hydrofiber® ; dressing to an alginate dressing in managing exuding venous leg ulcers in France.
Int Wound J
; 11(3): 304-13, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23020759
5.
Analysis of long-term clinical and cost impact of etranacogene dezaparvovec for the treatment of hemophilia B population in the United States.
J Med Econ
; 27(1): 758-765, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38708771
6.
Assessing health plan payer's budget impact of etranacogene dezaparvovec for the treatment of hemophilia B in the United States.
J Manag Care Spec Pharm
; : 1-12, 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38625717
7.
Matching-Adjusted Indirect Comparison of Recombinant Factor IX Albumin Fusion Protein Versus Recombinant Factor IX Fc Fusion Protein for Weekly Prophylactic Treatment of Hemophilia B.
Adv Ther
; 41(2): 649-658, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38070040
8.
Economic and humanistic burden in kidney transplant rejection: a literature review.
Expert Rev Pharmacoecon Outcomes Res
; 24(3): 343-352, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38284281
9.
Budget impact of prophylactic treatment of rVIII-SingleChain in moderate and severe hemophilia A in Italy.
J Med Econ
; 26(1): 554-564, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37039544
10.
Analysis of pooled real-world data from Germany, Italy, and the United States of rVIII-SingleChain compared with standard- and long-acting FVIII products for prophylaxis of hemophilia A.
Curr Med Res Opin
; 38(7): 1133-1139, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35387548
11.
A Real-World Analysis of Commonly Prescribed FVIII Products Based on U.S. Medical Charts: Consumption and Bleeding Outcomes in Hemophilia A Patients.
J Manag Care Spec Pharm
; 26(10): 1258-1265, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32820685
12.
The Authors Respond.
J Manag Care Spec Pharm
; 26(9): 1177-1178, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32857661
13.
A systematic review evaluating the efficacy and factor consumption of long-acting recombinant factor VIII products for the prophylactic treatment of hemophilia A.
J Med Econ
; 23(12): 1493-1498, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32969738
14.
Comparing Factor Use and Bleed Rates in U.S. Hemophilia A Patients Receiving Prophylaxis with 3 Different Long-Acting Recombinant Factor VIII Products.
J Manag Care Spec Pharm
; 26(4): 504-512, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32020842
15.
Assessing bleeding rates, related clinical impact and factor utilization in German hemophilia B patients treated with extended half-life rIX-FP compared to prior drug therapy.
Curr Med Res Opin
; 36(1): 9-15, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31469321
16.
Systematic review and analysis of efficacy of recombinant factor IX products for prophylactic treatment of hemophilia B in comparison with rIX-FP.
J Med Econ
; 22(10): 1014-1021, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31094591
17.
Analysis of Vascular Event Risk After Herpes Zoster From 2007 to 2014 US Insurance Claims Data.
Mayo Clin Proc
; 94(5): 763-775, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30955916
18.
Is patient insurance type related to physician recommendation, administration and referral for adult vaccination? A survey of US physicians.
Hum Vaccin Immunother
; 15(9): 2217-2226, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30785363
19.
Costs of herpes zoster complications in older adults: A cohort study of US claims database.
Vaccine
; 37(9): 1235-1244, 2019 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30685248
20.
Cost of herpes zoster and herpes zoster-related complications among immunocompromised individuals.
Vaccine
; 36(45): 6810-6818, 2018 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30249425